Overview Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients Status: Completed Trial end date: 2007-01-01 Target enrollment: Participant gender: Summary This study evaluates the safety of brimonidine/timolol fixed combination in glaucoma or ocular hypertension patients Phase: Phase 3 Details Lead Sponsor: AllerganTreatments: Brimonidine TartrateOphthalmic SolutionsPharmaceutical SolutionsTimolol